C. Mendiola
Impact in
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 4
-
- Ovarian cancer diagnosis and treatment 9
- Co-authors
- H. Cortés-Funes (13 shared papers)J. Lindtner (2 shared papers)Alan S. Coates (2 shared papers)Eva Ciruelos (6 shared papers)S. Pecorelli (2 shared papers)Luis Paz‐Ares (2 shared papers)José Mayordomo (2 shared papers)P. Lianes (2 shared papers)
In The Last Decade
C. Mendiola
28 papers receiving 386 citations
Peers
Comparison fields: 5 of 64
- Obstetrics and Gynecology 66
- Reproductive Medicine 71
- Oncology 158
- Cancer Research 56
- Surgery 81
Countries citing papers authored by C. Mendiola
This map shows the geographic impact of C. Mendiola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mendiola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mendiola more than expected).
Fields of papers citing papers by C. Mendiola
This network shows the impact of papers produced by C. Mendiola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mendiola. The network helps show where C. Mendiola may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Mendiola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 85 | |
| 2 | 2006 | 51 | |
| 3 | 1994 | 50 | |
| 4 | 2000 | 42 | |
| 5 | 2003 | 25 | |
| 6 | 2007 | 16 | |
| 7 | 2004 | 16 | |
| 8 | An international multicentre Phase III study of BAY 12-9566 (BAY) versus placebo in patients (pts) with advanced ovarian cancer (OVCA) responsive to primary surgery/Paclitaxel + Platinum containing chemotherapy (CT) | 2001 | 15 |
| 9 | 1998 | 13 | |
| 10 | Early clinical trial with quelamycin. | 1979 | 11 |
| 11 | 2012 | 10 | |
| 12 | 1993 | 10 | |
| 13 | 2009 | 10 | |
| 14 | 2013 | 9 | |
| 15 | 1982 | 9 | |
| 16 | 1997 | 8 | |
| 17 | A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results. | 1995 | 5 |
| 18 | 2017 | 4 | |
| 19 | 2012 | 4 | |
| 20 | 2001 | 4 |
About C. Mendiola
C. Mendiola is a scholar working on Oncology, Reproductive Medicine, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 412 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Ovarian cancer diagnosis and treatment (9 papers), Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Intraperitoneal and Appendiceal Malignancies (3 papers), Neuroblastoma Research and Treatments (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Obstetrics and Gynecology (66 citations), Reproductive Medicine (71 citations), Oncology (158 citations), Cancer Research (56 citations) and Surgery (81 citations). C. Mendiola has collaborated with scholars based in Spain, France and Italy. Frequent co-authors include H. Cortés-Funes, J. Lindtner, Alan S. Coates, Eva Ciruelos, S. Pecorelli, Luis Paz‐Ares, José Mayordomo, P. Lianes, Fernando Rivera and Jan B. Vermorken. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical & Translational Oncology, European Journal of Cancer and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.